Contribution: Industrial Research Assistance Program – Contributions to Firms
Neuraura Biotech Inc.
$49,382.00
In-house development and fabrication method for flex electrode arrays
FY 2020-21 · 2020-09-01
Summary
Neuraura currently uses a single specialist supplier for one step of the manufacturing process for its propriety cortical EEG electrode. To reduce reliance on external parties the company proposes to develop and institute a reliable in-house fabrication process and de-risk reliance, reduce overall manufacturing costs and protect IP and knowhow.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
744174483
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-04-30
Agreement Number
955435
Agreement Start Date
2020-09-01
Agreement Title
In-house development and fabrication method for flex electrode arrays
Agreement Title (French)
Méthode de conception et fabrication en interne de réseaux d'électrodes flexibles
Agreement Type
Contribution
Agreement Value
$49,382.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Neuraura currently uses a single specialist supplier for one step of the manufacturing process for its propriety cortical EEG electrode. To reduce reliance on external parties the company proposes to develop and institute a reliable in-house fabrication process and de-risk reliance, reduce overall manufacturing costs and protect IP and knowhow.
Description (French)
Neuraura fait actuellement appel à un seul fournisseur spécialisé pour une étape du procédé de fabrication de son électrode EEG cortical breveté. Afin de réduire la dépendance vis-à-vis des parties externes, l'entreprise propose de créer et de mettre en place un procédé de fabrication interne fiable et de réduire les risques, les coûts de fabrication généraux et de protéger la propriété intellectuelle et le savoir-faire.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Centre
Federal Riding (French)
Calgary-Centre
Federal Riding Number
48004
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
744174483
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Neuraura Biotech Inc.
Recipient Operating Name
Neuraura Biotech Inc.
Recipient Postal Code
T2P 5H1
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2020-2021-Q2-955435
